showed that PI3Kγ inhibition promotes NFκB activation and pro‐inflammatory transcription in myeloid cells, leading to anti‐tumour T cell activation and tumour inhibition that synergises with anti‐PD1 immune checkpoint blockade [30]. This evidence concerns the gene NFKB1 and neoplasm.